×
Entrez Id:
9971
Gene Symbol:
NR1H4
NR1H4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models.
30257410
2018
×
Entrez Id:
4023
Gene Symbol:
LPL
LPL
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin.
30214514
2018
×
Entrez Id:
2308
Gene Symbol:
FOXO1
FOXO1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats.
30186875
2018
×
Entrez Id:
57817
Gene Symbol:
HAMP
HAMP
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
29871592
2018
×
Entrez Id:
5264
Gene Symbol:
PHYH
PHYH
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
29031784
2018
×
Entrez Id:
3643
Gene Symbol:
INSR
INSR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
SusceptibilityMutation
RGD
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
28468951
2017
×
Entrez Id:
1728
Gene Symbol:
NQO1
NQO1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway.
28932253
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
ModifyingMutation
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
57817
Gene Symbol:
HAMP
HAMP
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
28051796
2017
×
Entrez Id:
3643
Gene Symbol:
INSR
INSR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice].
29325294
2017
×
Entrez Id:
4023
Gene Symbol:
LPL
LPL
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
27978932
2016
×
Entrez Id:
6347
Gene Symbol:
CCL2
CCL2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats.
25813056
2015
×
Entrez Id:
3416
Gene Symbol:
IDE
IDE
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats.
26576191
2015
×
Entrez Id:
9927
Gene Symbol:
MFN2
MFN2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis.
26401075
2015
×
Entrez Id:
7099
Gene Symbol:
TLR4
TLR4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Effect of electro-acupuncture on hepatic Toll-like receptor 4 and nuclear factor κB expressions in rats with non-alcoholic fatty liver disease].
25413054
2014
×
Entrez Id:
9971
Gene Symbol:
NR1H4
NR1H4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431
2014
×
Entrez Id:
10062
Gene Symbol:
NR1H3
NR1H3
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431
2014
×
Entrez Id:
2936
Gene Symbol:
GSR
GSR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.
24622831
2014
×
Entrez Id:
1571
Gene Symbol:
CYP2E1
CYP2E1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
25317811
2014
×
Entrez Id:
3156
Gene Symbol:
HMGCR
HMGCR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431
2014
×
Entrez Id:
27141
Gene Symbol:
CIDEB
CIDEB
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431
2014
×
Entrez Id:
64240
Gene Symbol:
ABCG5
ABCG5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431
2014
×
Entrez Id:
60
Gene Symbol:
ACTB
ACTB
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Protein carbonylation associated to high-fat, high-sucrose diet and its metabolic effects.
25282656
2014
×
Entrez Id:
498
Gene Symbol:
ATP5F1A
ATP5F1A
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Exposure to a northern contaminant mixture (NCM) alters hepatic energy and lipid metabolism exacerbating hepatic steatosis in obese JCR rats.
25222487
2014